← uz lielajiem investoriem
Adar1 Capital Management, LLC
institucionālais investors · portfelis $2.19 mljrd. · 277 pozīcijas · pārskats uz 30.06.2026
Akciju pozīcijas pārskats par 30.06.2026, iesniegts 14.08.2026; izmaiņas — pret 31.03.2026 · 0
| Uzņēmums | Akcijas | Vērtība | portfeļa % | Ceturkšņa izmaiņas |
|---|
Uzņēmumos, kas iekļauti mūsu datu bāzē 42
| Uzņēmums | Daļa | Akcijas | Pārskata datums |
|---|---|---|---|
| InflaRx N.V. | 20.15% | 3 000 000 | 2026-06-30 |
| Rallybio Corp | 17.21% | 926 352 | 2026-06-30 |
| InMed Pharmaceuticals Inc | 14.56% | 800 000 | 2026-06-30 |
| Amanat Acquisition Corp Clas… | 9.62% | 750 000 | 2026-06-30 |
| Pliant Therapeutics Inc | 8.9% | 5 509 724 | 2026-06-30 |
| Boundless Bio, Inc. | 8.65% | 1 968 216 | 2026-06-30 |
| Research Alliance Corporatio… | 8.36% | 650 000 | 2026-06-30 |
| LeonaBio, Inc. | 8.27% | 777 100 | 2026-06-30 |
| Cyclerion Therapeutics Inc | 6.38% | 298 757 | 2026-06-30 |
| Equillium Inc | 5.93% | 3 758 569 | 2026-06-30 |
| Editas Medicine Inc | 5.79% | 8 889 000 | 2026-06-30 |
| Helix Acquisition Corp. III… | 5.63% | 1 000 000 | 2026-06-30 |
| OnKure Therapeutics, Inc. | 5.54% | 2 238 684 | 2026-06-30 |
| JATT II Acquisition Corp. | 5.36% | 417 724 | 2026-06-30 |
| Inhibikase Therapeutics Inc | 5.29% | 7 387 205 | 2026-06-30 |
| Rein Therapeutics Inc | 5.22% | 4 500 000 | 2026-06-30 |
| CNS Pharmaceuticals Inc | 4.79% | 70 000 | 2026-06-30 |
| Enanta Pharmaceuticals Inc | 4.62% | 1 344 510 | 2026-06-30 |
| Adagio Medical Holdings, Inc | 4.39% | 1 205 447 | 2026-06-30 |
| Ovid Therapeutics Inc | 3.8% | 7 417 479 | 2026-06-30 |
| Kiora Pharmaceuticals Inc | 3.8% | 167 941 | 2026-06-30 |
| PepGen Ltd | 3.74% | 2 591 085 | 2026-06-30 |
| Korro Bio, Inc. | 3.67% | 540 054 | 2026-06-30 |
| Monopar Therapeutics Inc | 3.24% | 217 595 | 2026-06-30 |
| Anteris Technologies Global… | 3.23% | 3 145 096 | 2026-06-30 |
| enGene Therapeutics Inc. | 3.14% | 2 104 986 | 2026-06-30 |
| Prothena Corporation plc | 2.97% | 1 554 535 | 2026-06-30 |
| Zai Lab Ltd | 2.96% | 3 369 034 | 2026-06-30 |
| Acumen Pharmaceuticals Inc | 2.92% | 2 111 334 | 2026-06-30 |
| Corbus Pharmaceuticals Holdi… | 2.26% | 421 787 | 2026-06-30 |
| Inovio Pharmaceuticals Inc | 2.07% | 2 143 910 | 2026-06-30 |
| INVENTIVA | 1.73% | 3 606 656 | 2026-06-30 |
| Adlai Nortye Group Ltd. | 1.73% | 1 017 805 | 2026-06-30 |
| Prelude Therapeutics Inc | 1.13% | 900 900 | 2026-06-30 |
| Connect Biopharma Holdings L… | 1.11% | 700 000 | 2026-06-30 |
| Chemomab Therapeutics Ltd DR… | 1.1% | 80 000 | 2026-06-30 |
| Cue Biopharma | 0.76% | 55 193 | 2026-06-30 |
| Q/C Technologies, Inc. | 0.61% | 50 000 | 2026-06-30 |
| Neuphoria Therapeutics Inc | 0.55% | 30 000 | 2026-06-30 |
| PolyPid | 0.54% | 103 950 | 2026-06-30 |
| Longeveron LLC | 0.36% | 10 841 | 2026-06-30 |
| Korsana Biosciences, Inc. | 0.09% | 42 680 | 2026-06-30 |
reklāma